{"Name":"Alexo Therapeutics Limited","perma":"alexo-therapeutics-limited","BasicInfo":{"funded":"2015-01-01","isClosed":false,"closed":null,"short":"Alexo Therapeutics is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer."},"FundingRounds":[{"funding_type":"venture","series":"A","announcedDate":"2015-03-18","moneyRaised":36000000}],"Acquisitions":[],"AcquiredBy":null,"IPO":null,"Investments":[],"Products":[],"CurrentTeam":[{"title":"President and Chief Executive Officer","started":null,"ended":null,"firstName":"Jaume","lastName":"Pons"},{"title":"Chief Financial Officer","started":null,"ended":null,"firstName":"John","lastName":"Borgeson"}],"PastTeam":[]}
